Wegovy side effects: what to expect and how to manage them

What are the most common Wegovy side effects?

Digestive, almost across the board. Wegovy slows your stomach and turns down appetite signals — the exact mechanisms that drive the weight loss — so the most common side effects are your gut adjusting to a new pace.

Yes, those numbers run high — the highest reported in the GLP-1 class. Two things explain that without explaining it away. Wegovy is the highest dose semaglutide comes in (2.4 mg weekly, versus up to 2 mg for Ozempic), and the STEP 1 trial logged every complaint across a full 68 weeks — so “~44% reported nausea” means at some point during 16 months, not constantly. Most side effects were rated mild to moderate, and only about 7% of participants left the trial because of them (⚠ verify figure).

When do side effects start — and how long do they last?

Side effects track your dose schedule, not the calendar:

• First 1–2 weeks of a new dose — the peak window. Nausea and appetite whiplash show up as your body meets the higher level.
• Weeks 3–4 of each step — most effects fade noticeably as you adjust.
• After each dose increase — expect a smaller replay of the first-week pattern with every step up the 0.25 → 2.4 mg ladder.
• Long term — most people on a stable maintenance dose report few ongoing effects; constipation is the one that most often lingers.

A side effect that isn’t fading after a few weeks on the same dose is worth a call to your prescriber — staying longer at a lower dose is a standard, label-sanctioned move.

How to manage Wegovy side effects

Most of the playbook is mechanical: your stomach empties slower, so work with it, not against it.

Nausea

Smaller meals, eaten slowly. Cut fatty and fried food — it sits in your stomach longest. Cold or bland foods (crackers, rice, yogurt) beat rich ones. Stop eating at “no longer hungry” rather than “full,” because fullness now arrives on a delay. Ginger and vitamin B6 are low-risk adds. Vomiting you can’t stay ahead of isn’t a push-through situation — it’s a call.

Vomiting and diarrhea

Usually early, usually self-limiting — and the real risk with both is dehydration, which is how kidney trouble starts on this class. Water and electrolytes first, greasy meals off the menu, and a check-in with your provider if either lasts more than a couple of days.

Constipation

The most underestimated one, and the likeliest to linger. Water first — dehydration is the usual driver — then fiber (added gradually), daily movement, and a gentle over-the-counter option like magnesium or polyethylene glycol if needed (⚠ verify OTC framing). Regularly going 3–4 days without a bowel movement belongs on your next appointment’s agenda.

Headache and fatigue

Both showed up in trials, and both often trace to the same root: you’re suddenly eating and drinking much less. Hydrate deliberately, protect protein intake (it’s also how you protect muscle), and make sure you’re not under-eating to an extreme. Fatigue that deepens instead of fading isn’t typical — get it checked.

Injection-site reactions

Redness or itching at the site usually resolves in days. Rotate spots weekly — stomach, thigh, back of the arm — and let the pen sit out of the fridge a few minutes before injecting.

Serious side effects: when to call your provider

Rare, but they announce themselves. Don’t wait if you notice:

• Severe, persistent abdominal pain — possibly radiating to your back, with or without vomiting: the pancreatitis pattern.
• Upper-right belly pain, fever, or yellowing skin/eyes — gallbladder trouble; rapid weight loss itself raises gallstone risk.
• Signs of dehydration or reduced urination — vomiting and diarrhea can stress the kidneys.
• Low blood sugar (shakiness, sweating, confusion) — mainly if you also take insulin or a sulfonylurea; those combinations usually need dose adjustments.
• Vision changes, if you have type 2 diabetes — rapid blood-sugar improvement on semaglutide has been linked to temporary worsening of diabetic retinopathy. Report changes promptly.
• A lump or swelling in your neck, hoarseness, trouble swallowing — see the boxed warning below.
• Severe allergic reactions — swelling of face or throat, trouble breathing: emergency care, immediately.
• Mood changes or thoughts of self-harm — report them; this class is monitored for it.

You can report any side effect to the FDA’s MedWatch program — those reports are how post-market safety signals get caught.

Wegovy pill side effects: any different?

Not really. The daily 25 mg pill is the same molecule as the pen, and its trial program showed a roughly comparable GI profile (⚠ verify comparability wording) — nausea, diarrhea, and constipation still lead the list, and the boxed warning and serious-risk list carry over unchanged. The practical difference is rhythm: a daily dose means no weekly “injection day” spike, but it also means the label’s daily timing and food rules to follow. Cost-wise the pill is priced in line with the pen, so side effects and preference — not price — are the real tiebreakers.

Does Wegovy cause hair loss?

It can, indirectly. Hair shedding was reported more often with Wegovy than placebo in trials (⚠ verify rates), but the mechanism is almost always the weight loss itself — losing weight quickly pushes hair follicles into a resting phase (telogen effluvium). It’s temporary in the vast majority of cases. Protein intake, a slower dose ramp, and patience are the standard responses; shedding that continues past six months deserves a workup for iron, thyroid, and other causes.

Wegovy side effects in women

Two notes deserve their own flag:

• Pregnancy: Wegovy isn’t for use during pregnancy — weight loss offers no benefit and potential harm during it — and the label advises stopping in advance of a planned pregnancy (⚠ verify the recommended window). Make it an explicit planning conversation with your provider, not fine print.
• Cycle changes: some women report shifts in their menstrual cycle, but that hasn’t been established as a drug effect — rapid weight loss on its own can move hormones and cycles, and improved fertility with weight loss is a documented phenomenon worth knowing about.

One thing you may have seen on other GLP-1 pages that does not apply here: the advice to use backup birth control after starting or increasing doses comes from the tirzepatide (Zepbound) label, not Wegovy’s (⚠ verify absence on current semaglutide label).

Who should not take Wegovy?

Per the FDA label: anyone with a personal or family history of medullary thyroid carcinoma or MEN 2, anyone with a previous serious hypersensitivity reaction to semaglutide, and anyone pregnant. Caution flags your prescriber will weigh: a history of pancreatitis, severe GI disease like gastroparesis, diabetic retinopathy with type 2 diabetes, and insulin or sulfonylurea regimens that need adjusting first.